Biomarkers – Products

Syncell’s new Synlight-Pure Kit enables nanometer-scale proteomic mapping with unmatched specificity.

Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast cancer.

Roche’s SBX sequencing achieved a world record for the fastest human genome analysis and is driving breakthroughs in methylation mapping, spatial sequencing and multiomics research.

Syncell’s Microscoop Mint debuts in Europe at Max Planck and VIB, advancing subcellular proteomics and disease research.

CN Bio launches PhysioMimix Core, the first all-in-one organ-on-a-chip system for scalable, multi-organ drug discovery.

From ready-to-use to fully custom, CST solutions support developing, scaling, and delivering reproducible immunoassays quickly.

PacBio HiFi sequencing will profile ~7,800 LLFS participants to uncover genetic and epigenetic drivers of longevity.

Cyclana Bio raises £5M to develop tissue-level therapeutics, starting with new treatments for endometriosis.

This whitepaper provides a roadmap for leveraging advanced proteomics platforms to identify biomarkers capable of detecting disease at its earliest stages.

Bio-Rad to distribute Gencurix Droplex digital PCR cancer testing kits across Europe, advancing precision oncology diagnostics.